ST 6904
Alternative Names: ST-6904Latest Information Update: 15 Jan 2024
At a glance
- Originator Beijing Scitech-Mq Pharmaceuticals
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Brain metastases; Non-small cell lung cancer
Most Recent Events
- 19 Dec 2023 Preclinical trials in Brain metastases in China (unspecified route) prior to December 2023 (Beijing Scitech-Mq Pharmaceuticals pipeline, December 2023)
- 11 Dec 2023 Preclinical trials in Non-small cell lung cancer in China (unspecified route) prior to December 2023 (Beijing Scitech-Mq Pharmaceuticals pipeline, December 2023)